sun pharma's halol facility inspection by australian authorities positive?
Published 7 years ago • 951 plays • Length 2:40Download video MP4
Download video MP3
Similar videos
-
2:16
sun pharma's halol facility receives u.s. fda warning letter | business lunch | cnbc-tv18
-
2:36
u.s. fda issues warning letter to sun pharma, questions manufacturing practices at halol facility
-
2:16
sun pharma's halol details out
-
3:56
sun pharma news: u.s. fda lists company's halol plant under an import alert | halftime report
-
23:34
sun pharma in focus | us fda to re-inspect halol unit | movers & shakers | cnbc tv18
-
10:57
sun pharma row : dilip shanghvi assured investors of highest level of corporate governance
-
13:03
mega pharma deal: dilip shanghvi & israel makov ivu seg 3
-
5:25
sun pharma q4 profit rises 7%; beats estimates | #4qwithcnbctv18
-
1:15
us fda classifies the inspection at- sun pharma's dadra unit as oai, stock under pressure
-
1:25
sun pharma q1fy25: net profit, ebitda, margin beat est; us formulation sales at $466 m | cnbc tv18
-
3:06
sun pharma receives warning letter from us fda for its halol plant
-
0:54
sun pharma announces outcome of phase-1 obesity trial of gl0034 (utreglutide) | cnbc tv18
-
2:47
sun pharma halol plant | us fda issues 3 observations in form 483 | cnbc tv18
-
2:01
sun pharma to report its q2 results today, here is what expect | trading hour | cnbc-tv18
-
0:47
#shorts | sun pharma shares tank after us fda issues 10 observations to its halol facility
-
1:11
expect to meet the guidance this year: sun pharma
-
2:20
boost for sun pharma | u.s.fda nod for 1st product from halol | cnbc tv18
-
2:47
not aware of any whistleblower complaint : sun pharma on misgovernance allegations
-
1:23
sun pharma is a buying opportunity and you must keep it: sudarshan sukhani | cnbc tv18
-
1:26
what should you expect from sun pharma this q1?
-
1:19
sun pharma misses the mark in q4
-
3:16
decoding the highs & lows of pharma stocks in 2022 | business lunch | cnbc-tv18